Management of Chronic Myeloid Leukemia With BCR/ABL Inhibitors: Current Status and Future Perspectives

Clinical Medicine Insights: Therapeutics - New Zealand
doi 10.4137/cmt.s2439
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications